Theravance Biopharma Inc. (TBPH) declined -5.57% or -1.5 to $25.5. It is near 204620 shares traded, which is 153.38% compare to the average total volume 133404. The market cap of TBPH is $1.41 billion. The year to date change is -2.44%. The 52 week price range is from $21.27 to $35.48. Price of TBPH have changed -0.74% during last week. It have changed 1.62% over last month, 8.91% over last 3 months, 0.19% over last 6 months and -7.18% over one year.
Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for TBPH is 26.32. It is 3.22% above current price. The 200-day Moving Averages for TBPH is 26.42. It is 3.61% above current price. The 52-week High is 35.48. It is 39.14% from the current price. The 52-week Low is 21.27. It is -16.59% from current price.
There are some statistics of TBPH. It is has market cap $1.41 billion. The share outstanding is 55.41 million. The average volume is 133404. The percent of top 15 Institution holding is 146.00%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of TBPH is -298.90%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of TBPH is -59.21%.